Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

ADIAL PHARMACEUTICALS, INC. (ADIL)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-21Dec-31-20Dec-31-19Dec-31-18Dec-31-17Dec-31-16Dec-31-15
   10-K10-K10-K10-K10-KS-1S-1/A
Revenues  19.70.00.00.00.00.00.0
            Revenue growth    -100.0%31.8%   
Cost of goods sold  0.00.00.0-8.50.00.00.0
Gross profit  19.70.00.08.50.00.00.0
            Gross margin  100.0%  183032.6%0.0%  
Selling, general and administrative   [+]9.35.14.36.60.8264,664.0497,150.0
Research and development  8.45.94.00.40.2146,143.0322,107.0
Other operating expenses  19.3  8.5   
EBITDA   [+]-17.3     -818,127.0
            EBITDA margin  -87.5%  -150672.0%-28275.2%  
Depreciation  0.0     565.0
EBITA  -17.3-10.9-8.2-7.0-1.0-410,807.0-818,692.0
            EBITA margin  -87.5%  -150672.0%-28275.2%  
Amortization of intangibles  0.00.00.00.00.0 565.0
EBIT   [+]-17.3-10.9-8.2-7.0-1.0-410,807.0-819,257.0
            EBIT margin  -87.5%  -150684.1%-28291.2%  
Non-recurring items   [+]2.0      
Interest income, net   [+]0.00.00.1-1.2-0.1240.01,264.0
Other income (expense), net   [+]-0.20.0-0.4-3.5 -9,633.0 
Pre-tax income  -19.5-10.9-8.6-11.6-1.1-420,200.0-817,993.0
Income taxes  -0.10.00.00.00.00.00.0
            Tax rate  0.5%0.0%0.0%0.0%0.0%0.0%0.0%
Net income  -19.4-10.9-8.6-11.6-1.1-420,200.0-817,993.0
            Net margin  -98.4%  -250838.4%-32389.3%  
   
Basic EPS   [+]($1.04)($0.87)($0.87)($2.44)($6.54)($128,974.75) 
Diluted EPS   [+]($1.04)($0.87)($0.87)($2.44)($0.35)($128,974.75) 
   
Shares outstanding (basic)   [+]18.612.59.94.80.23.3 
Shares outstanding (diluted)   [+]18.612.59.94.83.33.3 
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy